Related Experiment Video
Updated: Mar 15, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Cardiac sarcoidosis - clinical manifestation and diagnosis]
Justyna Błaut-Jurkowska1, Piotr Podolec1, Maria Olszowska1
1Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Cracow, Poland.
Insights
Sarcoidosis can affect the heart in 5% of patients, causing conduction issues, arrhythmias, and heart failure. Early screening with ECG and echocardiogram is crucial for timely diagnosis and management of cardiac sarcoidosis.
Area of Science:
- Cardiology
- Immunology
- Internal Medicine
Background:
- Sarcoidosis is a multisystem inflammatory disease characterized by noncaseating granulomas.
- Cardiac involvement occurs in approximately 5% of sarcoidosis patients.
- The etiology of sarcoidosis remains unknown.
Purpose of the Study:
- To outline the diagnostic approach for cardiac sarcoidosis.
- To emphasize the importance of screening for cardiac sarcoidosis in affected individuals.
- To highlight the variable clinical presentation of cardiac sarcoidosis.
Main Methods:
- Clinical history, 12-lead electrocardiogram (ECG), and echocardiogram form the initial diagnostic algorithm.
- Advanced imaging techniques like cardiovascular magnetic resonance (CMR) and FDG-PET are used for further investigation.
- Endomyocardial biopsy is not routinely performed.
Main Results:
- Conduction abnormalities, arrhythmias, and heart failure are the most common manifestations of cardiac sarcoidosis.
- Screening is recommended for all patients with extracardiac sarcoidosis.
- Cardiac sarcoidosis can be the initial or sole manifestation in young patients with unexplained conduction abnormalities.
Conclusions:
- Cardiac sarcoidosis requires a high index of suspicion, especially in patients with unexplained conduction defects.
- A systematic diagnostic approach involving initial screening and advanced imaging is essential.
- Timely diagnosis and management are critical due to the potential severity of cardiac involvement.
Abstract:
Sarcoidosis is a multisystem inflammatory disease defined histologically by the formation of noncaseating granulomas. The etiology of sarcoidosis remains unknown. Heart involvement in the course of sarcoidosis concerns about 5% of patients. The most common manifestation of cardiac sarcoidosis are conduction abnormalities, arrhythmias and heart failure. The diagnostic algorithm includes performing a clinical history, a 12-lead electrocardiogram (ECG) and an echocardiogram. If any of the initial screening investigations yields an abnormality, diagnostics should be continue using advanced imaging techniques: cardiovascular magnetic resonance (CMR) or fluorodeoxyglucose positron emission tomography (FDG-PET). Nowadays endomyocardial biopsy is not performed routinely.The clinical picture of cardiac sarcoidosis is highly variable. Screening for cardiac sarcoidosis should be performed in all patients diagnosed with extracardiac sarcoidosis. Cardiac sarcoidosis should also be suspected in young patients without a diagnosis of sarcoidosis who present with conduction abnormalities of unknown etiology, because cardiac sarcoidosis may be the first or the only manifestation of the disease.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
